Pontoglio A: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) No edit summary |
Beno Marija (talk | contribs) |
||
| Line 12: | Line 12: | ||
{{Labelingperson}} | {{Labelingperson}} | ||
==Participated at== | ==Participated at== | ||
::::* [[MiPNet14.03 IOC50|IOC50]] | ::::* [[MiPNet14.03 IOC50|IOC50 Schroecken AT]] | ||
Latest revision as of 17:01, 12 February 2018
| Name | Pontoglio Alessandro, |
|---|---|
| Institution | Istituto di Biochimica e Biochimica Clinica
Policlinico A. Gemelli - Università Cattolica |
| Address | Largo A. Gemelli 8, 00168 |
| City | Roma |
| State/Province | |
| Country | Italy |
| espeedy@libero.it | |
| Weblink | |
| O2k-Network Lab | IT Rome Scatena R |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Tesori 2015 Sci Rep | 2015 | Tesori V, Piscaglia AC, Samengo D, Barba M, Bernardini C, Scatena R, Pontoglio A, Castellini L, Spelbrink JN, Maulucci G, Puglisi MA, Pani G, Gasbarrini A (2015) The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing. Sci Rep 5:9149. |
